skip nav
  Home | About CDC | Press Room | A-Z Index | Contact Us
spacer
CDC Centers for Disease Control and Prevention Home Page
CDC en Español
Search:  
CDC Home > HIV/AIDSTopics > Statistics and Surveillance > Reports > Reported CD4+ T-Lymphocyte Results for Adults and Adolescents with HIV/AIDS—33 States, 2005
spacer
spacer spacer
spacer
 
Skip Nav spacer
spacer
Table 1. Estimated distribution of reported results of the first CD4 test performed within 12 months after HIV diagnosis among adults and adolescents with HIV/AIDS, by selected characteristics, 2001–2003—33 states with confidential name-based HIV infection reporting
spacer
spacer
View PDF PDF icon

  CD4 count, cells/µLa
<200 200–350 351–500 >500 No CD4 count Total
  No. (%) No. (%) No. (%) No. (%) No. (%) No.b
Sex
Male 27,748 (33.3) 6,936 (8.3) 5,838 (7.0) 7,191 (8.6) 35,660 (42.8) 83,372
Female 9,542 (27.9) 2,697 (7.9) 2,284 (6.7) 3,159 (9.2) 16,509 (48.3) 34,191
Age as of end of year (yrs)
13–14 34 (22.3) 17 (11.2) 12 (7.7) 19 (12.3) 71 (46.4) 152
15–24 1,787 (14.0) 1,080 (8.4) 1,114 (8.7) 1,490 (11.7) 7,307 (57.2) 12,778
25–34 8,763 (27.3) 2,690 (8.4) 2,441 (7.6) 3,180 (9.9) 15,009 (46.8) 32,082
35–44 14,736 (34.6) 3,437 (8.1) 2,850 (6.7) 3,558 (8.4) 17,977 (42.2) 42,559
45–54 8,464 (38.9) 1,730 (8.0) 1,243 (5.7) 1,653 (7.6) 8,659 (39.8) 21,749
55–64 2,650 (41.9) 535 (8.5) 369 (5.8) 363 (5.7) 2,410 (38.1) 6,327
≥65 856 (44.7) 144 (7.5) 93 (4.9) 86 (4.5) 737 (38.5) 1,917
Transmission category
Male adult or adolescent
Male-to-male sexual contact 15,519 (30.9) 4,296 (8.6) 3,863 (7.7) 4,863 (9.7) 21,623 (43.1) 50,165
Injection drug use 5,243 (38.3) 1,085 (7.9) 838 (6.1) 966 (7.1) 5,569 (40.7) 13,701
Male-to-male sexual contact and injection drug use 1,412 (32.5) 407 (9.4) 349 (8.0) 557 (12.8) 1,620 (37.3) 4,345
Heterosexual contactc 5,315 (36.4) 1,104 (7.6) 761 (5.2) 778 (5.3) 6,655 (45.5) 14,612
Otherd 260 (47.2) 44 (8.0) 27 (5.0) 27 (4.8) 192 (35.0) 549
Female adult or adolescent
Injection drug use 2,201 (29.3) 583 (7.8) 494 (6.6) 729 (9.7) 3,515 (46.7) 7,522
Heterosexual contactc 7,104 (27.2) 2,062 (7.9) 1,761 (6.8) 2,397 (9.2) 12,763 (48.9) 26,087
Otherd 237 (40.7) 53 (9.0) 28 (4.9) 33 (5.6) 232 (39.8) 583
Race/ethnicity
White, not Hispanic 10,096 (30.1) 3,081 (9.2) 3,025 (9.0) 4,475 (13.4) 12,835 (38.3) 33,511
Black, not Hispanic 19,343 (32.0) 4,736 (7.8) 3,633 (6.0) 4,404 (7.3) 28,242 (46.8) 60,358
Hispanic 7,228 (33.5) 1,608 (7.5) 1,293 (6.0) 1,277 (5.9) 10,141 (47.1) 21,547
Asian/Pacific Islander 296 (31.5) 98 (10.4) 72 (7.7) 61 (6.5) 412 (43.8) 939
American Indian/Alaska Native 165 (29.7) 62 (11.2) 58 (10.4) 64 (11.6) 207 (37.2) 557
Unknown 162 (24.8) 48 (7.3) 41 (6.3) 68 (10.5) 332 (51.0) 651
Totale 37,290 (31.7) 9,633 (8.2) 8,122 (6.9) 10,350 (8.8) 52,169 (44.4) 117,564
Note. These numbers do not represent actual cases in persons with a diagnosis of HIV infection or AIDS. Rather, these numbers are point estimates of case counts that have been adjusted for reporting delays and for redistribution of cases in persons initially reported without an identified risk factor. The estimates have not been adjusted for incomplete reporting.
Since 2000, the following states have had laws or regulations requiring confidential name-based HIV infection reporting: Alabama, Alaska, Arizona, Arkansas, Colorado, Florida, Idaho, Indiana, Iowa, Kansas, Louisiana, Michigan, Minnesota, Mississippi, Missouri, Nebraska, Nevada, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, West Virginia, Wisconsin, and Wyoming. Since July 1997, Florida has had confidential name-based HIV infection reporting for new diagnoses only.
a When only CD4 percentage was available, a CD4 count was interpreted.
b Because row totals were calculated independently of the row values, the values in each row may not sum to the row total.
c With person at high risk or with a diagnosis of HIV infection or AIDS.
d Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or identified.
e Because column totals were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total.
Last Modified: March 14, 2006
Last Reviewed: March 14, 2006
Content Source:
Divisions of HIV/AIDS Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

 

spacer
spacer
spacer
spacer
  Home | Policies and Regulations | Disclaimer | e-Government | FOIA | Contact Us
spacer
spacer
spacer Safer, Healthier People
spacer
Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348, 24 Hours/Every Day - cdcinfo@cdc.gov.
spacer USA.gov: The U.S. Government's Official Web PortalDHHS Department of Health
and Human Services